深圳市有方科技股份有限公司 关于提前归还部分临时用于补充流动资金 的募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688159 证券简称：有方科技 公告编号：2025-060 2025年9月10日，公司将1,000万元提前归还至募集资金专用账户，截至本公告日，公司已累计归还临时 补充流动资金的募集资金1,000万元，剩余用于暂时补充流动资金的募集资金尚在董事会审议通过的使 用期限之内，公司将在规定到期日之前归还至募集资金专用账户，届时公司将及时履行信息披露义务。 公司将上述募集资金的归还情况通知了公司的保荐机构及保荐代表人。 特此公告。 深圳市有方科技股份有限公司董事会 2025年9月11日 深圳市有方科技股份有限公司（以下简称"公司"）于2025年3月12日召开第四届董事会第四次会议、第 四届监事会第三次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》。根据募 集资金投资项目的资金使用计划及项目的建设进度，公司及全资子公司在确 ...

Group 1 - The company plans to distribute cash dividends of 0.5 RMB per 10 shares, totaling 24,509,653.65 RMB, based on a total share capital of 490,193,073 shares as of June 30, 2025 [2][75][76] - The company reported a net profit attributable to shareholders of 184,951,506.16 RMB for the first half of 2025, with retained earnings of 1,535,205,734.32 RMB as of June 30, 2025 [75][76] - The board of directors approved the profit distribution plan on August 27, 2025, which is subject to shareholder meeting approval [77][78] Group 2 - The company has decided to waive its right of first refusal on the 50% equity stake in the joint venture company, Sinopec Wan Energy Natural Gas Co., Ltd., which is being offered for public transfer by Sinopec Natural Gas Co., Ltd. [4][5][9] - The estimated valuation of the joint venture is 75,558.77 million RMB, with the company's share of the stake valued at no less than 37,779.39 million RMB [5][6] - The decision to waive the right is expected to facilitate the introduction of other strategic investors to enhance the joint venture's business development [9] Group 3 - The company reported total assets of 260,615.78 million RMB and total liabilities of 190,598.99 million RMB for the joint venture as of June 30, 2025, with a net asset value of 70,016.79 million RMB [8] - The joint venture reported a net loss of 8.20 million RMB for the first half of 2025, compared to a net loss of 12.19 million RMB for the same period in 2024 [8] - The company maintains a 50% ownership stake in the joint venture, which remains unchanged despite the waiver of the right of first refusal [9]

证券代码：603085 证券简称：天成自控 公告编号：2025-060 浙江天成自控股份有限公司 关于 2019 年非公开发行股票募集资金投资项目结项 并将节余募集资金永久补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次结项的募集资金投资项目：2019 年非公开发行股票全部募集资金投 资项目 ? 节余募集资金使用计划：2019 年非公开发行股票节余募集资金 4,714.31 万元（最终转出金额以资金转出当日银行结算余额为准）将全部用于永久补充流 动资金。 ? 本事项已经第五届董事会第二十一次会议、第五届监事会第十六次会议 审议通过，无需提交股东大会审议。 浙江天成自控股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日召开 第五届董事会第二十一次会议、第五届监事会第十六次会议审议通过《关于 2019 年非公开发行募集资金投资项目结项并将节余募集资金永久补充流动资金的议 案》，同意公司将 2019 年非公开发行股票募集资金投资项目（以下简称"募投项 目"）结项，并将节余募 ...

Meeting Overview - The third meeting of the Supervisory Board of Guangdong Montai High-tech Fiber Co., Ltd. was held on August 22, 2025, with all three supervisors present [1][2] - The meeting was convened in accordance with legal regulations and the company's articles of association [1] Resolutions Passed - The Supervisory Board approved the "2025 Half-Year Report" and its summary, confirming that the report accurately reflects the company's situation without any false statements or omissions [1][2] - The board also approved the "Special Report on the Storage and Use of Raised Funds for the First Half of 2025," affirming compliance with relevant regulations and proper management of the funds [2][3] - A resolution was passed to change the investment projects and special account purposes for the raised funds, aimed at improving the efficiency of fund usage and optimizing resource allocation [2][3]

Fundraising Overview - The company raised a total of 304,465,200.00 RMB through a non-public offering of 22,620,000 shares at a price of 13.46 RMB per share, with a net amount of 299,191,994.34 RMB after deducting issuance costs [1][3] - As of June 30, 2025, the company has fully utilized the raised funds, totaling 307,738,979.79 RMB, which includes 173,510,804.21 RMB for project investments and 134,228,175.58 RMB for replenishing working capital [1][4] Fund Management - The company established a fundraising management system in compliance with relevant laws and regulations, including a tripartite supervision agreement with banks to ensure proper use of the funds [2][3] - The tripartite supervision agreement was terminated as the funds in the designated accounts were fully utilized and the accounts were closed by June 30, 2025 [2][3] Fund Usage - The company has used 118,335,682.85 RMB in the first half of 2025, with 3,489,586.28 RMB allocated to project investments and 114,846,096.57 RMB for working capital [4][5] - The company temporarily supplemented working capital with 115 million RMB from idle funds, which was fully returned to the designated account by May 21, 2025 [4][5] Project Adjustments - Several projects were terminated or concluded, including the "Yiwugong Trade Avenue Landscape Project," with remaining funds of 8,459,370.74 RMB allocated to working capital [5][6] - The company has adjusted the investment amounts for terminated projects, reallocating remaining funds to ensure operational liquidity [15][16] Compliance and Disclosure - The company confirmed that its fundraising usage and disclosures comply with legal and regulatory requirements, with no instances of misrepresentation or misuse of funds [7][8]

Meeting Details - The first session of the Supervisory Board's 11th meeting was held in the company's conference room, with a notification sent to all supervisors on July 16, 2025 [1] - Three supervisors were present, and the meeting was chaired by Shao Fusheng, complying with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the proposal regarding the use of raised funds to replace self-raised funds for investment projects, adjustment of project implementation entities, and confirmation of fund allocation amounts [1] - The board believes that the adjustments align with the actual situation and management requirements of the raised funds, enhancing the efficiency of fund usage and benefiting all shareholders [1] - The resolutions were passed with a unanimous vote of 3 in favor, with no opposition or abstentions [1]

Fundraising Overview - The company completed a non-public offering of 215,373,741 shares at a price of RMB 3.86 per share, raising a total of RMB 818,524,331.34 [1] - The funds were received on January 20, 2022, and were verified by Da Hua Accounting Firm [1] Fund Management and Usage - The company established dedicated accounts for the management of the raised funds, signing agreements with the sponsor, CITIC Securities, and various banks to ensure the safety of the funds [2] - As of the announcement date, all raised funds have been fully utilized, with a minimal remaining balance representing interest, approximately 0.00016% of the net amount raised [2] Account Closure - The company has completed the closure of the dedicated fundraising accounts, transferring the remaining balance of RMB 1,292.38 to other bank accounts for permanent working capital [2][3] - The closure of the accounts also terminates the related agreements with the sponsor and banks [3]

Fundraising Overview - Guodi Technology Co., Ltd. has successfully raised a total of RMB 467,804,160.00 by issuing 165,888,000 shares at a price of RMB 2.82 per share, with a net amount of RMB 459,265,712.30 after deducting related expenses [1][2]. Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations to ensure the proper use of raised funds and protect investor interests [2]. - A tripartite supervision agreement has been signed with Zheshang Securities Co., Ltd. and CITIC Bank Foshan Branch to ensure strict approval procedures for the use of raised funds [2]. Account Closure - The fundraising special account has been closed as the funds have been used in accordance with regulations, and the corresponding tripartite supervision agreement has been terminated [2][3].

Core Viewpoint - Vili Medical has received certification for its urological guide wire from the Canadian Ministry of Health, which allows for legal sales in the Canadian market, potentially enhancing overseas market promotion and sales [1][4]. Group 1: Company Announcements - Vili Medical's urological guide wire has been certified as a Class II medical device by the Canadian Ministry of Health, with the certification issued on May 28, 2025 [1][4]. - The company has completed the use of funds raised from its non-public stock issuance in 2021, totaling approximately 399.44 million yuan, with all fundraising accounts now closed [2][4]. - The funds were allocated to various projects, including the construction of a marketing center, production of anti-infection catheters, and the establishment of a research and development center [2]. Group 2: Financial Information - The non-public issuance involved 29,632,218 shares at a price of 13.48 yuan per share, resulting in a net amount of approximately 392.81 million yuan after expenses [2]. - The remaining balance of 2,456.97 yuan from the research and development project has been transferred to supplement working capital, with the project expected to be operational by December 31, 2025 [2].